{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:51:52Z","timestamp":1793447512373,"version":"4.5.0"},"reference-count":43,"publisher":"BMJ","license":[{"start":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T00:00:00Z","timestamp":1716249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj-2023-076797","type":"journal-article","created":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T07:15:13Z","timestamp":1716275713000},"page":"e076797","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Tackling the excesses of pharmaceutical marketing and promotion"],"prefix":"10.1136","volume":"385","author":[{"given":"Ravi","family":"Gupta","sequence":"first","affiliation":[{"name":"Divison of General Internal Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA"},{"name":"Department of Health Policy and Management, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reshma","family":"Ramachandran","sequence":"additional","affiliation":[{"name":"Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT, USA"},{"name":"Section of General Internal Medicine and National Clinician Scholars Program, Yale School of Medicine, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S","family":"Ross","sequence":"additional","affiliation":[{"name":"Collaboration for Regulatory Rigor, Integrity, and Transparency (CRRIT), Yale School of Medicine, New Haven, CT, USA"},{"name":"Section of General Internal Medicine and National Clinician Scholars Program, Yale School of Medicine, New Haven, CT, USA"},{"name":"Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA"},{"name":"Department of Health Policy and Management, Yale University School of Public Health, New Haven, CT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,5,21]]},"reference":[{"key":"2025110102305246000_385.may21_1.e076797.1","unstructured":"US Department of Justice. Biogen Inc agrees to pay $900 million to settle allegations related to improper physician payments. Press release, 26 Sep 2022. https:\/\/www.justice.gov\/opa\/pr\/biogen-inc-agrees-pay-900-million-settle-allegations-related-improper-physician-payments"},{"key":"2025110102305246000_385.may21_1.e076797.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2210637"},{"key":"2025110102305246000_385.may21_1.e076797.3","unstructured":"US Department of Justice. GlaxoSmithKline to plead guilty and pay $3 billion to resolve fraud allegations and failure to report safety data. Press release, 2 Jul 2012. https:\/\/www.justice.gov\/opa\/pr\/glaxosmithkline-plead-guilty-and-pay-3-billion-resolve-fraud-allegations-and-failure-report"},{"key":"2025110102305246000_385.may21_1.e076797.4","unstructured":"US Department of Justice. Novartis pays over $642 million to settle allegations of improper payments to patients and physicians. Press release, 1 Jul 2020. https:\/\/www.justice.gov\/opa\/pr\/novartis-pays-over-642-million-settle-allegations-improper-payments-patients-and-physicians"},{"key":"2025110102305246000_385.may21_1.e076797.5","doi-asserted-by":"publisher","DOI":"10.7326\/M20-5665"},{"key":"2025110102305246000_385.may21_1.e076797.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1855"},{"key":"2025110102305246000_385.may21_1.e076797.7","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2023.00146"},{"key":"2025110102305246000_385.may21_1.e076797.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040150"},{"key":"2025110102305246000_385.may21_1.e076797.9","doi-asserted-by":"publisher","DOI":"10.1086\/466973"},{"key":"2025110102305246000_385.may21_1.e076797.10","doi-asserted-by":"publisher","DOI":"10.1287\/mnsc.1110.1499"},{"key":"2025110102305246000_385.may21_1.e076797.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.19320"},{"key":"2025110102305246000_385.may21_1.e076797.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17436"},{"key":"2025110102305246000_385.may21_1.e076797.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.3.373"},{"key":"2025110102305246000_385.may21_1.e076797.14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.0482"},{"key":"2025110102305246000_385.may21_1.e076797.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpubeco.2021.104402"},{"key":"2025110102305246000_385.may21_1.e076797.16","doi-asserted-by":"publisher","DOI":"10.1002\/hec.4424"},{"key":"2025110102305246000_385.may21_1.e076797.17","doi-asserted-by":"publisher","DOI":"10.1002\/hec.3323"},{"key":"2025110102305246000_385.may21_1.e076797.18","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.2765"},{"key":"2025110102305246000_385.may21_1.e076797.19","doi-asserted-by":"publisher","DOI":"10.1257\/pol.20200044"},{"key":"2025110102305246000_385.may21_1.e076797.20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4189"},{"key":"2025110102305246000_385.may21_1.e076797.21","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2019.1082"},{"key":"2025110102305246000_385.may21_1.e076797.22","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2016.1709"},{"key":"2025110102305246000_385.may21_1.e076797.23","unstructured":"America\u2019s Health Insurance Plans. New study: in the midst of covid-19 crisis, 7 out of 10 big pharma companies spent more on sales and marketing than R&D. 2021. https:\/\/www.ahip.org\/news\/articles\/new-study-in-the-midst-of-covid-19-crisis-7-out-of-10-big-pharma-companies-spent-more-on-sales-and-marketing-than-r-d"},{"key":"2025110102305246000_385.may21_1.e076797.24","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.150032"},{"key":"2025110102305246000_385.may21_1.e076797.25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.1989"},{"key":"2025110102305246000_385.may21_1.e076797.26","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-04897-9"},{"key":"2025110102305246000_385.may21_1.e076797.27","unstructured":"Department of Health and Human Services. Office of Inspector General compliance program guidance for pharmaceutical manufacturers. 2003. https:\/\/oig.hhs.gov\/authorities\/docs\/03\/050503FRCPGPharmac.pdf"},{"key":"2025110102305246000_385.may21_1.e076797.28","unstructured":"US Office of Inspector General. Special fraud alert: speaker programs. 2020. https:\/\/oig.hhs.gov\/fraud\/docs\/alertsandbulletins\/2020\/SpecialFraudAlertSpeakerPrograms.pdf"},{"key":"2025110102305246000_385.may21_1.e076797.29","unstructured":"Pharmaceutical Research and Manufacturers of America (PhRMA). Code on interactions with health care professionals. 2021. https:\/\/www.phrma.org\/stem\/code-on-interactions-with-health-care-professionals"},{"key":"2025110102305246000_385.may21_1.e076797.30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001500"},{"key":"2025110102305246000_385.may21_1.e076797.31","unstructured":"United States of America v Biogen Idec, Inc. 1:12-cv-10601-IT: (D Mass. Jul 5, 2022)."},{"key":"2025110102305246000_385.may21_1.e076797.32","unstructured":"New York State Attorney General. Pharmaceutical giant agrees to historic settlement. Press release, 13 May 2004. https:\/\/ag.ny.gov\/press-release\/2004\/pharmaceutical-giant-agrees-historic-settlement\/"},{"key":"2025110102305246000_385.may21_1.e076797.33","unstructured":"National Resource Center for Academic Detailing. https:\/\/www.narcad.org\/"},{"key":"2025110102305246000_385.may21_1.e076797.34","doi-asserted-by":"publisher","DOI":"10.36076\/ppj.2017.s151"},{"key":"2025110102305246000_385.may21_1.e076797.35","doi-asserted-by":"publisher","DOI":"10.1111\/jlme.12073"},{"key":"2025110102305246000_385.may21_1.e076797.36","doi-asserted-by":"publisher","DOI":"10.1177\/0306312714525678"},{"key":"2025110102305246000_385.may21_1.e076797.37","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.0846"},{"key":"2025110102305246000_385.may21_1.e076797.38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMms2308188"},{"key":"2025110102305246000_385.may21_1.e076797.39","doi-asserted-by":"publisher","DOI":"10.1002\/smj.3509"},{"key":"2025110102305246000_385.may21_1.e076797.40","doi-asserted-by":"publisher","DOI":"10.1038\/nm0113-5"},{"key":"2025110102305246000_385.may21_1.e076797.41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001785"},{"key":"2025110102305246000_385.may21_1.e076797.42","doi-asserted-by":"publisher","DOI":"10.1177\/2631309X20970477"},{"key":"2025110102305246000_385.may21_1.e076797.43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001945"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj-2023-076797","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj-2023-076797","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:30:58Z","timestamp":1761989458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj-2023-076797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,21]]},"references-count":43,"alternative-id":["10.1136\/bmj-2023-076797"],"URL":"https:\/\/doi.org\/10.1136\/bmj-2023-076797","relation":{},"ISSN":["1756-1833"],"issn-type":[{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,21]]}}}